Latest New Zealand News

Uvre Limited has completed its acquisition of promising New Zealand gold assets and appointed seasoned mining executives to its board, setting the stage for an accelerated exploration phase.

City Chic Collective reports a promising FY25 with a return to profitability driven by strong ANZ sales and disciplined cost management, despite ongoing US market headwinds.

Abacus Storage King has received a revised acquisition proposal from a consortium led by Ki Corporation and Public Storage, increasing their cash offer by 15% to A$1.65 per security. The independent board committee is opening a six-week due diligence window but urges securityholders to hold off on any action.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Platinum Asia Investments Limited (PAI) has announced a proposed restructure via a scheme of arrangement to exchange its shares for units in the Platinum Asia Fund Complex ETF (PAXX), aiming to resolve a persistent discount to net tangible asset value (NTA). The scheme, supported by independent directors and deemed fair by an expert, includes a potential special dividend and awaits shareholder and court approval.

Tissue Repair Limited has secured major distribution partnerships in Australia, New Zealand, and Thailand for its TR Pro+® product line, marking a pivotal shift from development to commercialisation. The company is also scaling up manufacturing and advancing regulatory approvals to support its global expansion ambitions.

RBR Group Limited has launched a Share Purchase Plan to raise up to $650,000, offering eligible shareholders shares at a notably low price of $0.001 each. The funds will support a joint venture, repay convertible notes, and bolster working capital.

Pharmx Technologies has extended its pivotal National Diabetes Services Scheme agreement and expanded its supplier base, reinforcing its leadership in pharmacy digital infrastructure across Australia and New Zealand.

Australian Strategic Materials Limited (ASM) reminds eligible shareholders that its underwritten Share Purchase Plan closes on 17 July 2025, offering shares at a 20% discount. The plan is underwritten to $3 million by Canaccord Genuity, aiming to bolster ASM’s capital base.

Johns Lyng Group has entered a binding scheme implementation deed with Pacific Equity Partners for a $1.1 billion acquisition at $4.00 per share, representing a significant premium and a 10.3x EV/EBITDA multiple. The transaction awaits shareholder and regulatory approvals, with major shareholder backing and a clear timetable set for late 2025.

ikeGPS Group Limited has announced a fully underwritten A$18 million placement and a A$2 million share purchase plan to fund new product development and expand its market leadership in North America's utility software sector.